Skip to main content
    N

    Neuraxis, Inc. (NRXS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $4.83
    -0.59 (-10.89%)

    Market Cap: $76.93M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Neuraxis, Inc. (NRXS) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Neuraxis (NRXS) to earn -$0.81 per share in the fiscal year ending Dec 31, 2026, on revenue of $7.80M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.56.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 101.3%.

    Fiscal year ending Dec 31, 2026
    -$0.81
    EPS consensus, revenue $7.80M
    Fiscal year ending Dec 31, 2027
    -$0.56
    EPS consensus, revenue $15.70M
    Next report
    Mar 17, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.81-$0.81 to -$0.811$7.80M$7.80M to $7.80M1
    Dec 31, 2027-$0.56-$0.56 to -$0.561$15.70M$15.70M to $15.70M1

    Quarterly Estimates

    The EPS consensus falls from -$0.12 for the quarter ending Dec 31, 2026 to -$0.19 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.12-$0.18 to -$0.064$2.86M$2.16M to $3.57M4
    Mar 31, 2027-$0.19-$0.19 to -$0.191$2.70M$2.70M to $2.70M1

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 0 upward and 3 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202601
    Fiscal year ending Dec 31, 202701
    Quarter ending Mar 31, 202701

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.68.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$0.81-$0.76-$0.76-$0.76-$0.68N/A
    Fiscal year ending Dec 31, 2027-$0.56-$0.27-$0.27-$0.27-$0.06N/A
    Quarter ending Mar 31, 2027-$0.19-$0.16-$0.16-$0.16-$0.06N/A

    Frequently Asked Questions About NRXS

    What is the NRXS stock forecast?

    Consensus analyst estimates put Neuraxis's EPS at -$0.81 for the fiscal year ending Dec 31, 2026, on revenue of $7.80M.

    What EPS do analysts expect from NRXS next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.81, with estimates from -$0.81 to -$0.81 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.56, with estimates from -$0.56 to -$0.56 from 1 analyst.

    What revenue do analysts expect from Neuraxis next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $7.80M, with estimates from $7.80M to $7.80M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $15.70M, with estimates from $15.70M to $15.70M.

    How many analysts cover NRXS?

    1 analyst estimates EPS for Neuraxis for the fiscal year ending Dec 31, 2026.